These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17183742)

  • 1. Schizophrenia and the metabolic syndrome.
    Harv Ment Health Lett; 2006 Oct; 23(4):7. PubMed ID: 17183742
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amisulpride-associated acute onset of metabolic syndrome in a schizophrenia patient.
    Chang CK; Hung GC
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):131. PubMed ID: 23438173
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
    Keltner NL
    Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.
    Malhi G; Adams D; Plain J; Coulston C; Herman M; Walter G
    Australas Psychiatry; 2010 Feb; 18(1):32-41. PubMed ID: 20039791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational antipsychotic choice: weighing the risk of tardive dyskinesia and metabolic syndrome.
    Stoklosa J; Öngür D
    Harv Rev Psychiatry; 2011; 19(5):271-6. PubMed ID: 21916828
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
    Monteleone P; Martiadis V; Maj M
    Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up interventions in persons with schizophrenia and metabolic syndrome.
    Kølbæk P; Schiöth E; Aagaard J; Munk-Jørgensen P
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1059-60. PubMed ID: 25277542
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiometabolic conditions in patients with Schizophrenia.
    Wiwanitkit V; Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):54; author reply 54. PubMed ID: 21459740
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia, the metabolic syndrome and diabetes.
    Holt RI; Peveler RC; Byrne CD
    Diabet Med; 2004 Jun; 21(6):515-23. PubMed ID: 15154933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia.
    Na KS; Kim WH; Jung HY; Ryu SG; Min KJ; Park KC; Kim YS; Yoon JS; Ahn YM; Kim CE
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):295-300. PubMed ID: 22796278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome (MetS) in Lebanese patients with schizophrenia receiving atypical antipsychotic drugs.
    Bou Khalil R; Rohayem J; Abou Said N; El Chammay R; Haddad R; Richa S
    Asian J Psychiatr; 2013 Feb; 6(1):88-9. PubMed ID: 23380330
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular aspects of antipsychotics.
    Raedler TJ
    Curr Opin Psychiatry; 2010 Nov; 23(6):574-81. PubMed ID: 20838345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
    Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
    Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine and the development of the metabolic syndrome.
    Jalota R; Bond C; José RJ
    QJM; 2015 Mar; 108(3):245-7. PubMed ID: 22908317
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
    Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
    J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome.
    Shi L; Zhao Y; Fonseca V; Ascher-Svanum H; Chiang YJ; Winstead D
    Curr Med Res Opin; 2010 Oct; 26(10):2499-506. PubMed ID: 20828361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
    Housel AK; Waterbury N; Argo TR
    Issues Ment Health Nurs; 2009 Dec; 30(12):803-5. PubMed ID: 19916816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.